Neurodevelopmental disability · ventilated preterm infants with failure of initial non‐invasive respiratory support
1 finding from 1 review
Intraventricular haemorrhage, Papile grade 3/4 · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Neurodevelopmental disability · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Mortality before hospital discharge · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes mortality before hospital discharge compared with nCPAP used (very low certainty).
1 finding from 1 review
Endotracheal intubation To discharge · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV may leads to lower endotracheal intubation To discharge compared with nCPAP used (low certainty).
1 finding from 1 review
Chronic lung disease · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in chronic lung disease compared with nCPAP used (low certainty).
1 finding from 1 review
Adverse events · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes adverse events compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with growth‐hormone secreting pituitary adenomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgery for recurrent or persistent disease · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes surgery for recurrent or persistent disease compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review
Non‐surgical therapy for recurrent or persistent diseaseRadiation therapy and/or pharmacologic therapy for recurrent or persistent disease · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes non‐surgical therapy for recurrent or persistent diseaseRadiation… compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review
Health‐related quality of life · adults with growth‐hormone secreting pituitary adenomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease‐related complications Intubation difficulties requiring postponement of surgery · adults with growth‐hormone secreting pituitary adenomas
It is very uncertain whether surgery alone changes disease‐related complications Intubation difficulties requiring… compared with preoperative pharmacological therapy and surgery (very low certainty).
1 finding from 1 review
Recurrence · adults with growth‐hormone secreting pituitary adenomas
1 finding from 1 review
Change in patient‐reported symptom scores (lower is favored) · people with dry eye
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Mean change from baseline in meibum quality scores at 1 to 4 weeks (higher is favored) · people with dry eye
It is very uncertain whether lipiFlow changes mean change from baseline in meibum quality scores at 1 to 4 weeks… compared with basic warm compresses (very low certainty).
1 finding from 1 review
Mean change from baseline in meibomian gland atrophy scores at 1 to 4 weeks (lower is favored) · people with dry eye
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Proportion of participants with intervention‐related, vision‐threatening adverse events at 1 to 4 weeks · people with dry eye
1 finding from 1 review
Disease control (healing of skin lesions) at day 21 · bullous pemphigoid
Clobetasol propionate cream probably leads to higher disease control (healing of skin lesions) at day 21 compared with oral prednisone (moderate certainty).
1 finding from 1 review
Treatment‐related mortality at 1 year (mITT) · bullous pemphigoid
Doxycycline probably leads to lower treatment‐related mortality at 1 year (mITT) compared with prednisolone (moderate certainty).
1 finding from 1 review
Quality of life (DLQI) adjusted for baseline DLQI, disease severity, age, Karnovsky score, baseline versus week 52. A lower score is more favourable. · bullous pemphigoid
1 finding from 1 review